Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
Neuropediatrics|November 10, 2004
Nemaline rods and complex I deficiency in three infants with hypotonia, motor delay and failure to thriveP J Lamont, D R Thorburn, V Fabian, et al.
The Journal of Biological Chemistry|April 25, 1992
Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systemsM J Lohse, S Andexinger, J Pitcher, et al.
Arthritis and Rheumatism|May 1, 1992
The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic functionJ Martel-Pelletier, R McCollum, J DiBattista, et al.
Lancet (London, England)|October 9, 1982
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitisD C Dumonde, E Kasp-Grochowska, E Graham, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantationE Gluckman, I Jolivet, M L Scrobohaci, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1997
[Technique for protecting the liver graft less tolerant than the small bowel to heat-induced ischemia in experimental liver + small bowel transplantation in swine]J P Richer, J P Faure, T Dugue, et al.
Free Radical Biology & Medicine|January 3, 2001
2'-deoxyguanosine oxidation is associated with decrease in the DNA-binding activity of the transcription factor Sp1 in liver and kidney from diabetic and insulin-resistant ratsO Ramon, H K Wong, M Joyeux, et al.
British Journal of Haematology|March 1, 1990
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantationE Gluckman, I Jolivet, M L Scrobohaci, et al.
Nature Genetics|November 1, 2001
The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNAH Mandel, R Szargel, V Labay, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Immunocompromised Cas9 transgenic mice for rapid in vivo assessment of host factors involved in highly pathogenic virus infectionNicole Collette, Pragyesh Dhungel, Sean J Lund, et al.
Pageof 34